Funding opportunity

C3 ANNOUNCES REQUEST FOR APPLICATIONS FOR RESEARCH INTO CALPAINOPATHY

SYNOPSIS Coalition to Cure Calpain 3 (C3) provides funding for research and translational projects to expand the understanding of calpain 3 and Calpainopathy (including LGMD2A/R1 and LGMD1I/D4) to enable development of therapeutic approaches for this disease. This award is intended

FUNDING OPPORTUNITY! Coalition to Cure Calpain 3 Issues Request for Applications for Research Related to LGMD2A/R1

Coalition to Cure Calpain 3 requests applications for research and translational projects related to calpain 3 and limb-girdle muscular dystrophy type 2A (LGMD2A, also called LGMDR1 Calpain 3-related). The goal of the RFA is to enable the development of therapeutic

Dr. Stefanie Müthel Awarded First Early Career Investigator Travel Grant

Coalition to Cure Calpain 3 (C3) is pleased to announce that Dr. Stefanie Müthel was awarded a Travel Grant for the presentation of her research at the Biology of Calpains in Health and Disease Conference in Pacific Grove, California, from

C3 Introduces New Travel Grant Program for Calpainopathy Researchers

Coalition to Cure Calpain 3 (C3) will award Travel Grants to foster early career investigators who are currently conducting preclinical or clinical research in the area of calpainopathy (also known as Limb Girdle Muscular Dystrophy Type 2A or LGMD2A). The

Coalition to Cure Calpain 3 Announces Conclusion of Current Request for Application

The C3 RFA that was announced on September 15, 2016 is drawing to a close, and we request that all submissions, which we have been receiving on a rolling basis, be sent to Dr. Jennifer Levy no later than June